Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Directors Deals Ltd.
$12.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aerocrine AB says FeNO-measuring device NIOX MINO-09 is clear for commercialization in Japan


Monday, 25 Nov 2013 02:00am EST 

Aerocrine AB:Says on Nov. 19 the Japanese Pharmaceuticals and Medical Devices Agency’s (PMDA) granted the company regulatory approval for the 2009 version of its measuring device NIOX MINO as a tool for assessing patients with airway inflammation such as asthma.Says the approval opens up for marketing and sales of Aerocrine’s FeNO (fractional exhaled nitric oxide) measuring device in Japan and also means that Japanese physicians can receive reimbursement for FeNO tests. 

Company Quote

1.35
-0.02 -1.46%
17 Apr 2015